CTS Europe 2010: Leadership Gathering for Cell Therapy Industry
26/08/2010 10:40
Scalable B.V.
CTS Europe 2010: The Leadership Gathering for Cell Therapy Industry Executives
The Cell Therapy Summit Europe 2010, the first industry-focused leadership gathering in Europe will be held in Ch(aa)teau St. Gerlach, Maastricht, the Netherlands on October 20-21, 2010. During this Summit, CEOs, investors, academic researchers and other high-level executives will examine what it takes to create a successful business and establish a path forward for the mostly uncharted territory of cell therapy.
The growing roster of internationally recognized speakers includes:
- Mr. Tom Amick, Chairman and Chief Executive Officer, Aldagen
- Mr. Gil Beyen, Co-founder and Chief Executive Officer, Tigenix
- Mr. Eduardo Bravo, Chief Executive Officer, Cellerix
- William Caldwell, IV, Chairman and CEO, Advanced Cell Technology
- Dr. Robert Deans Ph.D., Vice President, Regenerative Medicine, Athersys
- Frederic Hammel, Chief Executive Officer, TxCell
- Martijn Kleijwegt, Founder & Managing Partner, Life Science Partners; Chairman of the Board, Kiadis
- Dr. Chris Mason, Director, Regenerative Medicine Bioprocessing Unit, University College London
The highly interactive program examines the entire development and commercialization process for cell therapies, including pre-clinical and clinical development, finance, business development, intellectual property, regulatory affairs and reimbursement.
Cell Therapy Summit Europe 2010 (CTS Europe 2010) is organized by the Alliance for Regenerative Medicine, PharmaCell and Limburg Ventures.
Additional information about the event and the registration information can be found on the conference website www.ctsconference.com.
http://www.ctsconferece.com